Table 3.

Association between selected Shh pathway–related SNPs and bladder cancer risk

GeneSNPGenotypeCase/controlOR (95% CI)*P
GLI3rs3735361 (G>A)GG/GA708/733Reference
Flanking 3′ UTRAA95/701.42 (1.01-1.99)0.04
rs3823720 (G>A)GG/GA704/738Reference
3′ UTRAA99/651.57 (1.11-2.20)0.01
rs10951671 (G>A)GG/GA748/769Reference
IntronAA55/341.75 (1.11-2.74)0.02

Abbreviations: OR, odds ratio; UTR, untranslated region.

  • *Adjusted by age, gender, and smoking status.